Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

patients aged >75 years with idiopathic PAH and multiple risk factors for left heart failure, patients with severe liver disease); these patients should be treated with monotherapy. As there have ...

Although some cases of PAH have known causes, such as genetic factors, many cases have no identifiable ... The 2022 ESC/ERS guidelines provide detailed risk stratification charts and subsequent ...

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.

heritable PAH (due to genetic factors), and PAH associated with connective tissue diseases, congenital heart diseases, drugs/toxins, and other conditions. Elevated pressures in the pulmonary ...

Asian American, Native Hawaiian and other Pacific Islander (AANHPI) populations experienced differences in both cardiovascular disease predicted risk and risk factors, according to preliminary ...

Adding Winrevair to standard pulmonary arterial hypertension (PAH) treatment is generally safe and effective, a pooled trial ...